跳至主要内容
临床试验/NCT00768196
NCT00768196已完成不适用

Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients

AstraZeneca1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
2,000
试验地点
1
主要终点
The primary variable is the total rate of GERD patients who had EED symptom and effect on their quality of life.

研究概览

简要总结

The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • GERD patients who have experienced heartburn or acid regurgitation during past 7 days
  • GERD patients who have already undergone endoscopy before enrolment

排除标准

  • Involvement in the planning and conduct of the programme
  • The person who took the medicine such as PPI or H2RA during the last 7 days
  • Severe systemic disease

结局指标

主要结局

The primary variable is the total rate of GERD patients who had EED symptom and effect on their quality of life.

次要结局

  • The secondary variable is the comparison of the EED symptom frequency in ERD and NERD patients.

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验